The People's Perspective on Medicine
Kisunla (Donanemab): Breakthrough or Boondoggle Against Alzheimer’s?
The FDA has just approved the anti-amyloid drug Kisunla (donanemab). Is this medication an important advance against Alzheimer's disease?
Personalized Approach Can Lower Risk for Dementia
Older people have a lower risk for dementia if they can address several risk factors such as sedentary habits, depression or hypertension.
Why Would the FDA Approve Ineffective Drugs?
Many doctors believe that FDA's standards for approving new drugs are very high. How come there are many ineffective drugs on the market?
The People's Perspective on Medicine© 2024 The People's Pharmacy
All Rights Reserved